₂₄Keiichi I Nakayama

Summary for 2004 [at-glance overview of Keiichi I Nakayama work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Keiichi I Nakayama. According to available data, in 2004 Keiichi I Nakayama published at least 24 articles. This work was completed in collaboration with several authors including Hatakeyama, Shigetsugu and Nakayama, Keiko. Many other authors have collaborated with Keiichi I Nakayama as well. There is no information about the funding or the grants awarded to support this work.

Keiichi I Nakayama is a key opinion leader in numerous areas including Cell Cycle Proteins, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Ubiquitin, Cyclin-Dependent Kinase Inhibitor p27. This author's highest rank is 1 when compared to all other authors using the keyword Cell Cycle Proteins. Analysis of the article abstracts and the titles suggests that Keiichi I Nakayama professional interests are focused around "retinal pigment epithelium", "cell nuclear antigen" and "oxidative stress response". These might also be referred to as "p27 kip1", "ubiquitin ligase" or "ad4bp sf-1". Statistical analysis shows that Keiichi I Nakayama's writing is likely to contains terms "p27", "kip1", "protein", "cells", "degradation" and "mice".

The affiliations of Keiichi I Nakayama vary, with Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan being the most prominent. Luckily, several email addresses are on file.

ENFRESRU

make correctionleave commentask question

Images [images we found on the Internet for Keiichi I Nakayama]

loading...

Do you know Keiichi I Nakayama who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Keiichi I Nakayama]

• ₈Nakayama, K I